1. Home
  2. TRN vs MIRM Comparison

TRN vs MIRM Comparison

Compare TRN & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRN
  • MIRM
  • Stock Information
  • Founded
  • TRN 1933
  • MIRM 2018
  • Country
  • TRN United States
  • MIRM United States
  • Employees
  • TRN N/A
  • MIRM N/A
  • Industry
  • TRN Railroads
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRN Industrials
  • MIRM Health Care
  • Exchange
  • TRN Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • TRN 2.3B
  • MIRM 2.5B
  • IPO Year
  • TRN N/A
  • MIRM 2019
  • Fundamental
  • Price
  • TRN $26.81
  • MIRM $53.05
  • Analyst Decision
  • TRN Hold
  • MIRM Strong Buy
  • Analyst Count
  • TRN 1
  • MIRM 9
  • Target Price
  • TRN $24.00
  • MIRM $66.22
  • AVG Volume (30 Days)
  • TRN 749.9K
  • MIRM 423.5K
  • Earning Date
  • TRN 07-31-2025
  • MIRM 08-06-2025
  • Dividend Yield
  • TRN 4.47%
  • MIRM N/A
  • EPS Growth
  • TRN 8.99
  • MIRM N/A
  • EPS
  • TRN 1.63
  • MIRM N/A
  • Revenue
  • TRN $2,855,000,000.00
  • MIRM $379,251,000.00
  • Revenue This Year
  • TRN N/A
  • MIRM $35.83
  • Revenue Next Year
  • TRN $6.29
  • MIRM $16.83
  • P/E Ratio
  • TRN $16.47
  • MIRM N/A
  • Revenue Growth
  • TRN N/A
  • MIRM 69.31
  • 52 Week Low
  • TRN $23.01
  • MIRM $36.20
  • 52 Week High
  • TRN $39.83
  • MIRM $54.78
  • Technical
  • Relative Strength Index (RSI)
  • TRN 48.40
  • MIRM 61.93
  • Support Level
  • TRN $26.02
  • MIRM $50.96
  • Resistance Level
  • TRN $27.05
  • MIRM $53.59
  • Average True Range (ATR)
  • TRN 0.59
  • MIRM 1.61
  • MACD
  • TRN -0.21
  • MIRM -0.13
  • Stochastic Oscillator
  • TRN 24.16
  • MIRM 70.02

About TRN Trinity Industries Inc.

Trinity Industries Inc. sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in three main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: